<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The largest number of studies found in Brazil is justified by the fact that Brazil has an extremely rich biodiversity, corresponding to approximately 20% of all living species known globally, comprising over 45,000 species of higher plants. In addition, the Brazilian population has a historical tradition in the use of medicinal plants for the treatment of different diseases, including acute and/or chronic inflammation disorders [
 <xref rid="B54" ref-type="bibr" class="xref">54</xref>, 
 <xref rid="B55" ref-type="bibr" class="xref">55</xref>]. Another interesting fact is the number of studies conducted in China and India, which may be justified as a reflection of the contribution of Oriental medicine in the search and development for new drugs from natural products. In fact, traditional Chinese medicine (TCM) and Ayurveda as major traditional treatment systems used not only in India and China but also in several countries contributed to the development of new pharmaceutical products based on plant species [
 <xref rid="B56" ref-type="bibr" class="xref">56</xref>â€“
 <xref rid="B58" ref-type="bibr" class="xref">58</xref>].
</p>
